| Annual Financials | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 37 | 56 | 50 | 41 | 54 | 0 |
| Expenses | 35 | 54 | 48 | 38 | 51 | 0 |
| EBITDA | 1 | 2 | 3 | 3 | 3 | 0 |
| Operating Profit % | 4 % | 4 % | 5 % | 6 % | 5 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 1 | 2 | 2 | 1 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 1 | 0 |
| EPS in ₹ | 2.69 | 3.96 | 3.61 | 2.49 | 2.57 | 0.00 |
Saroja Pharma Industries
Saroja Pharma Industries
32.50
0.00
(0.00%)
Market Cap
13.07 Cr
PE Ratio
12.65
Volume
1,600.00
Day High - Low
32.50 - 32.50
52W High-Low
60.00 - 28.00
Key Fundamentals
Market Cap
13.07 Cr
EPS
2.57
PE Ratio
12.65
PB Ratio
0.83
Book Value
38.99
EBITDA
3.00
Dividend Yield
0.00 %
Industry
Chemicals Sector
Specialty Chemicals Return on Equity
6.60
Debt to Equity
0.50
Actual
Company News
View All News
Saroja Pharma Industries India Limited reported a 56.4% rise in net profit to ₹161.80 crore for FY26. Revenue from operations increased 30.5% to ₹7,012.90 crore.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,457.20 | #1 1,48,308.90 | 61.10 | 14,600.80 | 9.06 | #1 2,474 | 36.65 | 54.21 | |
2,696.20 | 79,922.06 | 43.91 | #1 15,416.40 | 3.98 | 1,835 | 10.63 | 55.10 | |
3,612.00 | 39,677.82 | 69.50 | 4,996.00 | 2.94 | 569 | -42.93 | 47.72 | |
6,998.50 | 35,854.70 | 54.64 | 3,313.90 | 38.48 | 664 | #1 123.79 | 52.61 | |
603.40 | 30,444.04 | 40.46 | 4,832.00 | 3.60 | 755 | 33.44 | 58.66 | |
1,670.10 | 22,779.00 | 41.68 | 7,887.07 | -5.72 | 566 | 8.54 | 42.31 | |
6,685.50 | 19,683.29 | #1 29.18 | 6,273.54 | 10.21 | 729 | 62.26 | 42.08 | |
470.90 | 17,074.57 | 41.05 | 8,286.00 | 13.73 | 365 | 42.71 | 49.13 | |
1,328.20 | 15,121.33 | 65.95 | 2,365.46 | #1 63.30 | 203 | -10.97 | 45.98 | |
1,115.70 | 14,802.48 | 66.30 | 1,160.14 | 31.79 | 240 | 7.36 | 48.46 |
Growth Rate
Revenue Growth
31.78 %
Net Income Growth
11.11 %
Cash Flow Change
12.75 %
ROE
10.00 %
ROCE
9.05 %
EBITDA Margin (Avg.)
-18.01 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 8 | 16 | 21 | 27 | 40 |
| Fixed Assets | 0 | 0 | 2 | 3 | 3 |
| Current Assets | 8 | 15 | 16 | 18 | 27 |
| Capital Work in Progress | 0 | 0 | 2 | 6 | 9 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 15 | 17 | 18 | 28 |
| Total Equity & Liabilities | 8 | 16 | 21 | 27 | 40 |
| Current Liabilities | 6 | 10 | 13 | 9 | 23 |
| Non Current Liabilities | 1 | 2 | 3 | 3 | 1 |
| Total Equity | 1 | 4 | 5 | 15 | 16 |
| Reserve & Surplus | 1 | 4 | 2 | 11 | 12 |
| Share Capital | 0 | 0 | 3 | 4 | 4 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | 0 | 0 | 0 |
| Investing Activities | -0 | -0 | -5 | -5 | -3 |
| Operating Activities | -1 | -4 | 2 | 1 | 1 |
| Financing Activities | 1 | 4 | 3 | 4 | 2 |
Share Holding
| % Holding | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
| Promoter | 73.02 % | 73.02 % | 73.02 % | 73.02 % | 73.02 % | 73.02 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 24.32 % | 24.08 % | 24.04 % | 24.00 % | 23.60 % | 22.60 % |
| Others | 2.67 % | 2.91 % | 2.94 % | 2.98 % | 3.38 % | 4.38 % |
| No of Share Holders | 641 | 506 | 438 | 422 | 435 | 413 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 62.70 | 58.25 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 58.45 | 54.00 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 45.00 | 41.90 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 43.15 | 41.25 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 33.00 | 32.50 |
Technical Indicators
RSI(14)
Neutral 48.60
ATR(14)
Less Volatile 1.04
STOCH(9,6)
Neutral 66.75
STOCH RSI(14)
Overbought 84.21
MACD(12,26)
Bullish 0.59
ADX(14)
Weak Trend 22.61
UO(9)
Bearish 47.03
ROC(12)
Uptrend And Accelerating 15.45
WillR(14)
Neutral -35.71
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
